Novel Mouse Model of Myocardial Infarction, Plaque Rupture, and Stroke Shows Improved Survival With Myeloperoxidase Inhibition
Circulation · 27.08.2024 · 150 (9) · 687-705
DOI: 10.1161/circulationaha.123.067931 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 27.08.2024. Verfasst von Sohel Shamsuzzaman und 20 weiteren Autor:innen. Beteiligte Einrichtung: Robert M. Berne Cardiovascular Research Center (S. Shamsuzzaman, R.A.D., A.S., V.S., V.M.M., S.K. S. Saibaba, L.S.S., G.K.O.), University of Virginia…. Hauptthemen laut MEDLINE: Myocardial Infarction, Peroxidase, Plaque, Atherosclerotic, Stroke. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Themen: Schlaganfall
Abstract (Originalsprache)
BACKGROUND: Thromboembolic events, including myocardial infarction (MI) or stroke, caused by the rupture or erosion of unstable atherosclerotic plaques are the leading cause of death worldwide. Although most mouse models of atherosclerosis develop lesions in the aorta and carotid arteries, they do not develop advanced coronary artery lesions. Moreover, they do not undergo spontaneous plaque rupture with MI and stroke or do so at such a low frequency that they are not viable experimental models to study late-stage thrombotic events or to identify novel therapeutic approaches for treating atherosclerotic disease. This has stymied the development of more effective therapeutic approaches for reducing these events beyond what has been achieved with aggressive lipid lowering. Here, we describe a diet-inducible mouse model that develops widespread advanced atherosclerosis in coronary, brachiocephalic, and carotid arteries with plaque rupture, MI, and stroke. METHODS: We characterized a novel mouse model with a C-terminal mutation in the scavenger receptor class B, type 1 (SR-BI), combined with Ldlr knockout (designated SR-BI ∆CT/∆CT / Ldlr −/− ). Mice were fed Western diet (WD) for 26 weeks and analyzed for MI and stroke. Coronary, brachiocephalic, and carotid arteries were analyzed for atherosclerotic lesions and indices of plaque stability. To validate the utility of this model, SR-BI ∆CT/∆CT / Ldlr −/− mice were treated with the drug candidate AZM198, which inhibits myeloperoxidase, an enzyme produced by activated neutrophils that predicts rupture of human atherosclerotic lesions. RESULTS: SR-BI ∆CT/∆CT / Ldlr −/− mice show high (>80%) mortality rates after 26 weeks of WD feeding because of major adverse cardiovascular events, including spontaneous plaque rupture with MI and stroke. Moreover, WD-fed SR-BI ∆CT/∆CT / Ldlr −/− mice displayed elevated circulating high-sensitivity cardiac troponin I and increased neutrophil extracellular trap formation within lesions compared with control mice. Treatment of WD-fed SR-BI ∆CT/∆CT / Ldlr −/− mice with AZM198 showed remarkable benefits, including >90% improvement in survival and >60% decrease in the incidence of plaque rupture, MI, and stroke, in conjunction with decreased circulating high-sensitivity cardiac troponin I and reduced neutrophil extracellular trap formation within lesions. CONCLUSIONS: WD-fed SR-BI ∆CT/∆CT / Ldlr −/− mice more closely replicate late-stage clinical events of advanced human atherosclerotic disease than previous models and can be used to identify and test potential new therapeutic agents to prevent major adverse cardiac events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Robert M. Berne Cardiovascular Research Center (S. Shamsuzzaman, R.A.D., A.S., V.S., V.M.M., S.K. S. Saibaba, L.S.S., G.K.O.), University of Virginia School of Medicine, Charlottesville.
- Department of Biochemistry and Molecular Genetics (A.S., K.W.), University of Virginia School of Medicine, Charlottesville.
- Hematovascular Biology Center, Robert M. Berne Cardiovascular Research Center (H.D., M.A.E., K.W., S.B.), University of Virginia School of Medicine, Charlottesville.
- Department of Pharmacology (V.S.), University of Virginia School of Medicine, Charlottesville.
- Department of Molecular Physiology and Biophysics (V.M.M., G.K.O.), University of Virginia, Charlottesville.
- Program in Fundamental Neuroscience (S. Saibaba), University of Virginia, Charlottesville.
ORCID-Profile: Sohel Shamsuzzaman, Rebecca A Deaton, Anita Salamon, Heather Doviak, Vlad Serbulea, Victoria M Milosek, Megan A Evans, Santosh Karnewar, Gabriel F Alencar, Laura S Shankman, Kenneth Walsh, Stefan Bekiranov, Monty Krieger, Marie Persson, Erik Michaëlsson, Gary K Owens
Förderung
- NHLBI NIH HHS
Zitieren
APA
Shamsuzzaman, S., Deaton, R. A., Salamon, A., Doviak, H., Serbulea, V., Milosek, V. M., Evans, M. A., Karnewar, S., Saibaba, S., Alencar, G. F., Shankman, L. S., Walsh, K., Bekiranov, S., Kocher, O., Krieger, M., Kull, B., Persson, M., Michaëlsson, E., Bergenhem, N., …, & Owens, G. K. (2024). Novel Mouse Model of Myocardial Infarction, Plaque Rupture, and Stroke Shows Improved Survival With Myeloperoxidase Inhibition. Circulation, 150(9), 687-705. https://doi.org/10.1161/circulationaha.123.067931
Vancouver
Shamsuzzaman S, Deaton RA, Salamon A, Doviak H, Serbulea V, Milosek VM, et al. Novel Mouse Model of Myocardial Infarction, Plaque Rupture, and Stroke Shows Improved Survival With Myeloperoxidase Inhibition. Circulation. 2024;150(9):687-705. doi:10.1161/circulationaha.123.067931
BibTeX
@article{Shamsuzzaman2024,
author = {Shamsuzzaman, Sohel and Deaton, Rebecca A and Salamon, Anita and Doviak, Heather and Serbulea, Vlad and Milosek, Victoria M and Evans, Megan A and Karnewar, Santosh and Saibaba, Subhi and Alencar, Gabriel F and Shankman, Laura S and Walsh, Kenneth and Bekiranov, Stefan and Kocher, Olivier and Krieger, Monty and Kull, Bengt and Persson, Marie and Michaëlsson, Erik and Bergenhem, Nils and Heydarkhan-Hagvall, Sepideh and Owens, Gary K},
title = {Novel Mouse Model of Myocardial Infarction, Plaque Rupture, and Stroke Shows Improved Survival With Myeloperoxidase Inhibition},
journal = {Circulation},
year = {2024},
volume = {150},
number = {9},
pages = {687--705},
doi = {10.1161/circulationaha.123.067931}
}
EUVIMED